Regenerative Medicine Advanced Therapy Archives

Humacyte’s Humacyl receives US FDA expedited review designation

22nd March 2017

The US Food and Drug Administration (FDA) has granted Humacyte’s Humacyl investigational human acellular vessel (HAV) Regenerative Medicine Advanced Therapy (RMAT) designation. This designation means...

Write to us
Editor: Jocelyn Hudson [email protected]
Advertising: Rav Pankhania [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: Regenerative Medicine Advanced Therapy

Humacyte’s Humacyl receives US FDA expedited review designation